Chiaki Takahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chiaki Takahashi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Hajime Iizuka
Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan
3 shared publicationsJiro Uehara
Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan
2 shared publicationsYasushi Ohishi
Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan
2 shared publicationsAkemi Ishida-Yamamoto
Department of Dermatology, Asahikawa Medical University, Hokkaido, Japan
1 shared publicationAkemi Ishida‐Yamamoto
Department of Dermatology Asahikawa Medical University Hokkaido Japan
1 shared publication- Akemi Ishida‐Yamamoto
Department of Dermatology Asahikawa Medical University Asahikawa Japan
1 shared publication
Latest Publications
- 28 May 2015
- Published by Wiley in The Journal of Dermatology
- Vol. 42 (10) , 999-1001
Cutaneous S100‐negative, CD1a‐positive histiocytosis successfully treated with combination therapy of oral methotrexate and corticosteroid
S100‐negative, CD1a‐positive histiocytosis is a rare histiocytic disorder characterized by proliferation of histiocytic cells possessing a phenotype of epidermal Langerhans cells except for the lack of S100 expression and Birbeck granules. We report the case of a Japanese man suffering from S100‐negative, CD1a‐positive histiocytosis. The patient showed numerous smooth erythematous 5–10‐mm papules/nodules on most of his body. The key histopathological feature was the presence of dermal infiltrates of non‐epidermotropic S100‐negative CD1a‐positive mononuclear cells. No systemic involvement was detected. Initially bath‐psoralen plus ultraviolet A therapy was effective, but the lesions became recalcitrant to this treatment. Methylprednisolone pulse therapy followed by low‐dose methotrexate (up to 30 mg/week) in combination with prednisolone (15 mg/day) effectively controlled the skin lesions.
- 28 May 2015
- Published by Wiley in The Journal of Dermatology
- Vol. 42 (10) , 999-1001
Cutaneous S100‐negative, CD1a‐positive histiocytosis successfully treated with combination therapy of oral methotrexate and corticosteroid
S100‐negative, CD1a‐positive histiocytosis is a rare histiocytic disorder characterized by proliferation of histiocytic cells possessing a phenotype of epidermal Langerhans cells except for the lack of S100 expression and Birbeck granules. We report the case of a Japanese man suffering from S100‐negative, CD1a‐positive histiocytosis. The patient showed numerous smooth erythematous 5–10‐mm papules/nodules on most of his body. The key histopathological feature was the presence of dermal infiltrates of non‐epidermotropic S100‐negative CD1a‐positive mononuclear cells. No systemic involvement was detected. Initially bath‐psoralen plus ultraviolet A therapy was effective, but the lesions became recalcitrant to this treatment. Methylprednisolone pulse therapy followed by low‐dose methotrexate (up to 30 mg/week) in combination with prednisolone (15 mg/day) effectively controlled the skin lesions.
- 21 May 2015
- Published by Wiley in The Journal of Dermatology
- Vol. 42 (8) , 842-844
Malignant melanoma on female clitoris with bidirectional upper and lower lymphatic flow
- 21 May 2015
- Published by Wiley in The Journal of Dermatology
- Vol. 42 (8) , 842-844
Malignant melanoma on female clitoris with bidirectional upper and lower lymphatic flow
- 13 February 2015
- Published by Wiley in The Journal of Dermatology
- Vol. 42 (4) , 430-432
Multiple poromas following combination chemotherapy and autologous peripheral blood stem cell transplantation
- 13 February 2015
- Published by Wiley in The Journal of Dermatology
- Vol. 42 (4) , 430-432
Multiple poromas following combination chemotherapy and autologous peripheral blood stem cell transplantation